AAAAAA
Results: 1-25/27
Authors:
Wang, H
Marsters, SA
Baker, T
Chan, B
Lee, WP
Fu, L
Tumas, D
Yan, MH
Dixit, VM
Ashkenazi, A
Grewal, IS
Citation: H. Wang et al., TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice, NAT IMMUNOL, 2(7), 2001, pp. 632-637
Authors:
Lawrence, D
Shahrokh, Z
Marsters, S
Achilles, K
Shih, D
Mounho, B
Hillan, K
Totpal, K
DeForge, L
Schow, P
Hooley, J
Sherwood, S
Pai, R
Leung, S
Khan, LL
Gliniak, B
Bussiere, J
Smith, CA
Strom, SS
Kelley, S
Fox, JA
Thomas, D
Ashkenazi, A
Citation: D. Lawrence et al., Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions, NAT MED, 7(4), 2001, pp. 383-385
Authors:
Pollack, IF
Erff, M
Ashkenazi, A
Citation: If. Pollack et al., Direct stimulation of apoptotic signaling by soluble Apo2L/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells, CLIN CANC R, 7(5), 2001, pp. 1362-1369
Authors:
Chuntharapai, A
Dodge, K
Grimmer, K
Schroeder, K
Marsters, SA
Koeppen, H
Ashkenazi, A
Kim, KJ
Citation: A. Chuntharapai et al., Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4, J IMMUNOL, 166(8), 2001, pp. 4891-4898
Authors:
Kischkel, FC
Lawrence, DA
Tinel, A
LeBlanc, H
Virmani, A
Schow, P
Gazdar, A
Blenis, J
Arnott, D
Ashkenazi, A
Citation: Fc. Kischkel et al., Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8., J BIOL CHEM, 276(49), 2001, pp. 46639-46646
Authors:
Roth, W
Isenmann, S
Nakamura, M
Platten, M
Wick, W
Kleihues, P
Bahr, M
Ohgaki, H
Ashkenazi, A
Weller, M
Citation: W. Roth et al., Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis, CANCER RES, 61(6), 2001, pp. 2759-2765
Authors:
Ashkenazi, A
Grewal, IS
Dixit, VM
Citation: A. Ashkenazi et al., Secreted IgM versus BLyS in germinal center formation - Response, NAT IMMUNOL, 1(3), 2000, pp. 179-179
Authors:
Yan, MH
Marsters, SA
Grewal, IS
Wang, H
Ashkenazi, A
Dixit, VM
Citation: Mh. Yan et al., Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity, NAT IMMUNOL, 1(1), 2000, pp. 37-41
Authors:
Kischkel, FC
Lawrence, DA
Chuntharapai, A
Schow, P
Kim, KJ
Ashkenazi, A
Citation: Fc. Kischkel et al., Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5, IMMUNITY, 12(6), 2000, pp. 611-620
Authors:
Marsters, SA
Yan, MH
Pitti, RM
Haas, PE
Dixit, VM
Ashkenazi, A
Citation: Sa. Marsters et al., Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI, CURR BIOL, 10(13), 2000, pp. 785-788
Authors:
Cohen, HA
Ashkenazi, A
Barzilai, A
Lahat, E
Citation: Ha. Cohen et al., Nocturnal acute laryngospasm in children: A possible epileptic phenomenon, J CHILD NEU, 15(3), 2000, pp. 202-204
Authors:
Kischkel, FC
Ashkenazi, A
Citation: Fc. Kischkel et A. Ashkenazi, Combining enhanced metabolic labeling with immunoblotting to detect interactions of endogenous cellular proteins, BIOTECHNIQU, 29(3), 2000, pp. 506
Authors:
Ashkenazi, A
Tanny, J
Citation: A. Ashkenazi et J. Tanny, Vacuum transparent insulation for visualization of solidification phenomena, EXP FLUID, 28(5), 2000, pp. 482-484
Authors:
Halaas, O
Vik, R
Ashkenazi, A
Espevik, T
Citation: O. Halaas et al., Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages, SC J IMMUN, 51(3), 2000, pp. 244-250
Authors:
Ashkenazi, A
Kaufman, Y
Ben-Hur, T
Citation: A. Ashkenazi et al., Bilateral focal motor status epilepticus with retained consciousness afterstroke, NEUROLOGY, 54(4), 2000, pp. 976-978
Authors:
Zhou, Q
Fukushima, P
DeGraff, W
Mitchell, JB
Stetler-Stevenson, M
Ashkenazi, A
Steeg, PS
Citation: Q. Zhou et al., Radiation and the Apo2L/TRAIL apoptotic pathway preferentially inhibit thecolonization of premalignant human breast cells overexpressing cyclin D1, CANCER RES, 60(10), 2000, pp. 2611-2615
A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL
Authors:
Hymowitz, SG
O'Connell, MP
Ultsch, MH
Hurst, A
Totpal, K
Ashkenazi, A
de Vos, AM
Kelley, RF
Citation: Sg. Hymowitz et al., A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL, BIOCHEM, 39(4), 2000, pp. 633-640
Authors:
Hymowitz, SG
Christinger, HW
Fuh, G
Ultsch, M
O'Connell, M
Kelley, RF
Ashkenazi, A
de Vos, AM
Citation: Sg. Hymowitz et al., Triggering cell death: The crystal structure of Apo2L/TRAIL in a complex with death receptor 5, MOL CELL, 4(4), 1999, pp. 563-571
Authors:
Johnsen, AC
Haux, J
Steinkjer, B
Nonstad, U
Egeberg, K
Sundan, A
Ashkenazi, A
Espevik, T
Citation: Ac. Johnsen et al., Regulation of Apo-2 ligand/trail expression in NK cells - Involvement in NK cell-mediated cytotoxicity, CYTOKINE, 11(9), 1999, pp. 664-672
Authors:
Gurney, AL
Marsters, SA
Huang, A
Pitti, RM
Mark, M
Baldwin, DT
Gray, AM
Dowd, P
Brush, J
Heldens, S
Schow, P
Goddard, AD
Wood, WI
Baker, KP
Godowski, PJ
Ashkenazi, A
Citation: Al. Gurney et al., Identification of a new member of the tumor necrosis factor family and itsreceptor, a human ortholog of mouse GITR, CURR BIOL, 9(4), 1999, pp. 215-218
Authors:
Ashkenazi, A
Dixit, VM
Citation: A. Ashkenazi et Vm. Dixit, Apoptosis control by death and decoy receptors, CURR OP CEL, 11(2), 1999, pp. 255-260
Authors:
Ashkenazi, A
Freeman, S
Argov, Z
Citation: A. Ashkenazi et al., Effects of cholinergic blockers on auditory brain-stem evoked potentials in rats, J NEUR SCI, 164(2), 1999, pp. 124-128
Authors:
Chuntharapai, A
Gibbs, V
Lu, J
Ow, A
Marsters, S
Ashkenazi, A
De Vos, A
Kim, KJ
Citation: A. Chuntharapai et al., Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2, J IMMUNOL, 163(2), 1999, pp. 766-773
Authors:
Mori, S
Murakami-Mori, K
Nakamura, S
Ashkenazi, A
Bonavida, B
Citation: S. Mori et al., Sensitization of AIDS Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D, J IMMUNOL, 162(9), 1999, pp. 5616-5623
Authors:
Ashkenazi, A
Pai, RC
Fong, S
Leung, S
Lawrence, DA
Masters, SA
Blackie, C
Chang, L
McMurtrey, AE
Hebert, A
DeForge, L
Koumenis, IL
Lewis, D
Harris, L
Bussiere, J
Koeppen, H
Shahrokh, Z
Schwall, RH
Citation: A. Ashkenazi et al., Safety and antitumor activity of recombinant soluble Apo2 ligand, J CLIN INV, 104(2), 1999, pp. 155-162